National Research Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 1/6
National Research's earnings have been declining at an average annual rate of -4.4%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 3.3% per year. National Research's return on equity is 78.2%, and it has net margins of 18.8%.
Anahtar bilgiler
-4.4%
Kazanç büyüme oranı
-3.6%
EPS büyüme oranı
Healthcare Sektör Büyümesi | 8.5% |
Gelir büyüme oranı | 3.3% |
Özkaynak getirisi | 78.2% |
Net Marj | 18.8% |
Son Kazanç Güncellemesi | 30 Sep 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12
Jun 19National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon
Jun 04Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)
May 09National Research's (NASDAQ:NRC) Dividend Will Be $0.12
Feb 20National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Dec 13Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital
Oct 01We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt
Jul 10Why We Like The Returns At National Research (NASDAQ:NRC)
May 04Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
Mar 25National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Nov 17National Research Corp: Market Is Discounting These Key Factors
Sep 18National Research declares $0.24 dividend
Aug 23National Research GAAP EPS of $0.33, revenue of $37.3M
Aug 02National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively
Jul 13Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
May 27National Research Corp.: Quality/Low Risk On Sale
May 17The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested
Mar 21National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly
Feb 11Gelir ve Gider Dağılımı
National Research nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Sep 24 | 144 | 27 | 44 | 0 |
30 Jun 24 | 146 | 29 | 45 | 0 |
31 Mar 24 | 147 | 30 | 46 | 0 |
31 Dec 23 | 149 | 31 | 47 | 0 |
30 Sep 23 | 149 | 29 | 46 | 0 |
30 Jun 23 | 148 | 29 | 45 | 0 |
31 Mar 23 | 150 | 30 | 44 | 0 |
31 Dec 22 | 152 | 32 | 43 | 0 |
30 Sep 22 | 152 | 35 | 42 | 0 |
30 Jun 22 | 152 | 36 | 41 | 0 |
31 Mar 22 | 151 | 37 | 40 | 0 |
31 Dec 21 | 148 | 37 | 39 | 0 |
30 Sep 21 | 144 | 36 | 38 | 0 |
30 Jun 21 | 140 | 36 | 36 | 0 |
31 Mar 21 | 135 | 35 | 35 | 0 |
31 Dec 20 | 133 | 37 | 34 | 0 |
30 Sep 20 | 131 | 38 | 34 | 0 |
30 Jun 20 | 130 | 36 | 35 | 0 |
31 Mar 20 | 130 | 36 | 34 | 0 |
31 Dec 19 | 128 | 32 | 33 | 0 |
30 Sep 19 | 126 | 31 | 33 | 0 |
30 Jun 19 | 124 | 30 | 32 | 0 |
31 Mar 19 | 120 | 31 | 31 | 0 |
31 Dec 18 | 120 | 30 | 31 | 0 |
30 Sep 18 | 119 | 29 | 31 | 0 |
30 Jun 18 | 118 | 26 | 32 | 0 |
31 Mar 18 | 118 | 24 | 31 | 0 |
31 Dec 17 | 118 | 23 | 30 | 0 |
30 Sep 17 | 116 | 22 | 29 | 0 |
30 Jun 17 | 114 | 23 | 27 | 0 |
31 Mar 17 | 112 | 21 | 28 | 0 |
31 Dec 16 | 109 | 20 | 28 | 0 |
30 Sep 16 | 107 | 21 | 28 | 0 |
30 Jun 16 | 106 | 20 | 28 | 0 |
31 Mar 16 | 104 | 19 | 27 | 0 |
31 Dec 15 | 102 | 17 | 27 | 0 |
30 Sep 15 | 101 | 16 | 28 | 0 |
30 Jun 15 | 100 | 16 | 27 | 0 |
31 Mar 15 | 99 | 16 | 26 | 0 |
31 Dec 14 | 99 | 18 | 25 | 0 |
30 Sep 14 | 97 | 18 | 24 | 0 |
30 Jun 14 | 95 | 17 | 25 | 0 |
31 Mar 14 | 94 | 16 | 25 | 0 |
31 Dec 13 | 93 | 15 | 25 | 0 |
Kaliteli Kazançlar: NRC has high quality earnings.
Büyüyen Kar Marjı: NRC's current net profit margins (18.8%) are lower than last year (19.3%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: NRC's earnings have declined by 4.4% per year over the past 5 years.
Büyüme Hızlandırma: NRC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: NRC had negative earnings growth (-5.8%) over the past year, making it difficult to compare to the Healthcare industry average (11.4%).
Özkaynak Getirisi
Yüksek ROE: Whilst NRC's Return on Equity (78.22%) is outstanding, this metric is skewed due to their high level of debt.